lenalidomide,elotuzumab,carfilzomib,dexamethasone
abbvie,bms
['revlimid', 'krd ', 'kyprolis', 'empliciti']
empliciti-kyprolis-revlimid-dex outperforms krd in ndmm, 1st positive data of empliciti in front line #myeloma #asco23 
Multiple Myeloma Research Foundation - Accelerating the development of next generation #myeloma treatments to extend patient’s lives, and lead to a cure.